| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |